ToxStrategies

Innovative Solutions / Sound Science

Newsletter Signup
  • Services
    • Air Quality
    • Animal Feed and Pet Food
    • Bioaccessibility and Relative Bioavailability of Metals
    • Biopharmaceuticals / Pharmaceuticals
    • Cannabinoid and Industrial Hemp Safety
    • Causation Analysis
    • Coal Combustion Residuals
    • Computational Toxicology
    • Cosmetics & Personal Care Products Qualifications
    • Cumulative Impact Assessment
    • Developmental, Reproductive, and Juvenile Toxicity
    • Endocrine Disruption Evaluation
    • Environmental Liability Cost Analysis
    • Environmental Sciences
    • Epidemiology and Biostatistics
    • Epigenetics
    • Exposure Assessment
    • Food Defense and Intentional Adulteration
    • Food and Supplement Safety 
    • Food Safety and Preventive Controls
    • Food Safety Modernization Act (FSMA)
    • Foreign Supplier Verification Program
    • GHS: OSHA and REACH/CLP
    • Health Economics and Outcomes Research (HEOR) Overview
    • Industrial Hygiene
    • Medical Devices Qualifications
    • Neurotoxicology and Neuroscience
    • New Approach Methods (NAMs) and Alternatives to Animal Testing
    • Ocular Toxicology
    • PBPK and IVIVE
    • Per-and Polyfluoralkyl Substances (PFAS)
    • Pesticides
    • Process Authority and Microbial Risk Assessment
    • Proposition 65
    • Quantitative Structure-Activity Relationship (QSAR) Modeling
    • Radiation Risk Assessment and Management
    • Risk Assessment
    • Risk Communication
    • Sustainability and Global Product Stewardship
    • Systematic Reviews and Evidence-Based Toxicology
    • Toxicology
    • Toxicology Monographs
    • TSCA
  • Publications
    • Abstracts and Presentations
    • Book Chapters
    • Manuscripts
    • Protocol Registrations
  • People
  • Careers
  • Company
    • Our Mission
    • Latest News
    • Locations
    • People
    • Newsletter Signup
    • Careers
    • Divisions
    • Contact Us
  • Publications
  • ToxStrategies Consulting Services
  • People
  • Our Company
  • Careers
  • Locations
  • Newsletter Signup
  • Latest News
  • Divisions
  • Contact Us

Author Archives: cmccormick

Post navigation

← Older posts
Newer posts →

New Publications Advance the Study of Cannabinoid Safety 

October 3, 2023 by cmccormick

This gallery contains 2 photos.

ToxStrategies scientist Dr. Rayetta Henderson is among the authors of two new articles published by the journal Cannabis and Cannabinoid Research. Together, these… read more

Posted in Latest News |

ToxStrategies scientists publish study on potential dietary intake limits for cannabidiol (CBD)

September 21, 2023 by cmccormick

ToxStrategies scientists have published a manuscript in the journal Regulatory Toxicology and Pharmacology reporting the outcome of a state-of-the-science assessment to develop recommendations… read more

Posted in Latest News |

Dr. Sampedro Joins ToxStrategies’ Foods and Consumer Products Practice

September 19, 2023 by cmccormick

This gallery contains 1 photo.

We are thrilled to announce that Dr. Fernando Sampedro has joined ToxStrategies LLC, bringing his broad expertise and depth of experience to our Foods… read more

Posted in Latest News |

Dr. Michael Kelsh joins EpidStrategies, a Division of ToxStrategies LLC

September 14, 2023 by cmccormick

This gallery contains 1 photo.

EpidStrategies, a Division of ToxStrategies LLC, is pleased to announce the addition of Dr. Michael Kelsh to our team, adding considerable depth to… read more

Posted in Latest News |

ToxStrategies scientists presenting at The Charles River Biotech Symposium

September 6, 2023 by cmccormick

ToxStrategies scientists Marcie Wood, Ph.D. and Kirsten Mease, B.S. will be presenting at The Charles River Biotech Symposium – Biotechnology-Derived Therapeutics Perspectives on… read more

Posted in Latest News |

How are Decisions Made Regarding Safe Levels of Radiation in the Environment?

August 29, 2023 by cmccormick

For more than a century, radiation health has been a concern for the public and for workers. However, the launch of the Hollywood… read more

Posted in Latest News |

New Infant RSV Prevention to be Available this Fall

August 17, 2023 by cmccormick

This gallery contains 2 photos.

In the United States, a new monoclonal antibody (nirsevimab; trade name: Beyfortus) was recently approved by the FDA and recommended by the CDC… read more

Posted in Latest News |

New Requirements under the EPA Coal Combustion Residuals Rule: Legacy and Environmental Justice

August 15, 2023 by cmccormick

Coal Combustion Residuals (CCRs) are generated from the combustion of coal in producing steam for generation of electricity by electric utilities and independent… read more

Posted in Latest News |

Post navigation

← Older posts
Newer posts →

Our Publications

published
Click here to see some of our recently published articles and abstracts.

COPYRIGHT ©2025 ToxStrategies, a BlueRidge Life Science Company All Rights Reserved.  |  Privacy Policy  |  Terms of Use